4 unknown. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Eye Abnormalities: new trials by email Literature Review of Eye Abnormalities trials Research Report on Eye Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy Bromfenac Sodium - Familial Exudative Vitreoretinopathies | Phase 2 | Unknown | Seoul National University Hospital | 39 | 2021-11-01 | 2023-11-22 |
| An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. sepofarsen - Leber Congenital Amaurosis 10, Blindness | Phase 2 / Phase 3 | Unknown | ProQR Therapeutics | 15 | 2021-03-23 | 2022-03-25 |
| Single Ascending Dose Study in Participants With LCA10 EDIT-101 - Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies | Phase 1 / Phase 2 | Unknown | Editas Medicine, Inc. | 34 | 2019-09-26 | 2022-12-05 |
| Prosthetic Motility and Complications in Pegged Versus Unpegged Hydroxyapatite Orbital Implants orbital implant - Anophthalmos, Orbital Implants | Phase 2 / Phase 3 | Unknown | Shahid Beheshti University of Medical Sciences | 50 | 2005-11-01 | 2010-05-12 |
Leber Congenital Amaurosis (2) · Leber Congenital Amaurosis 10 (2) · Meckel Syndrome, Type 4 (2) · Retinal Degeneration (2) · Retinal Diseases (2) · Vision Disorders (2) · Anophthalmos (1) · Blindness (1) · Congenital Abnormalities (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Familial Exudative Vitreoretinopathies (1) · Genetic Diseases, Inborn (1) · Neurologic Manifestations (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Congenital Abnormalities (3) · Eye Diseases (3) · Eye Diseases, Hereditary (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Genetic Diseases, Inborn (1) · Neurologic Manifestations (1) · Retinal Diseases (1) · Sensation Disorders (1)
Orbital Implants (1) · bromfenac (1)
Editas Medicine, Inc. (1) · ProQR Therapeutics (1) · Seoul National University Hospital (1) · Shahid Beheshti University of Medical Sciences (1)
Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Iran (1) · Italy (1) · Netherlands (1) · South Korea (1) · United Kingdom (1) · United States (1)
Babak Babsharif, MD (1) · Jeong Hun Kim, MD, PhD (1)